AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pignatelli, P.
Right arrow Articles by Violi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pignatelli, P.
Right arrow Articles by Violi, F.
Agricola
Right arrow Articles by Pignatelli, P.
Right arrow Articles by Violi, F.
American Journal of Clinical Nutrition, Vol. 72, No. 5, 1150-1155, November 2000
© 2000 American Society for Clinical Nutrition

Original Research Communication

The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide1,2

Pasquale Pignatelli, Fabio M Pulcinelli, Andrea Celestini, Luisa Lenti, Andrea Ghiselli, Pier Paolo Gazzaniga and Francesco Violi

1 From the Department of Experimental Medicine and Pathology, Institute of 1st Clinical Medicine, University La Sapienza, National Institute for Nutrition, Rome.

2 Address reprint requests to PP Gazzaniga, Dipartimento di Medicina Sperimentale e Patologia, Università degli Studi di Roma La Sapienza, Viale Regina Elena 324, 00161 Rome, Italy. E-mail: gazzaniga{at}.uniroma1.it.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Epidemiologic studies have shown an inverse relation between moderate consumption of red wine and cardiovascular disease. Studies have shown that red wine and its component flavonoids inhibit in vivo platelet activation, but the underlying mechanism has not yet been identified.

Objective: Because we showed previously that collagen-induced platelet aggregation is associated with a burst of hydrogen peroxide, which in turn contributes to stimulating the phospholipase C pathway, the aim of this study was to investigate whether flavonoids synergize in inhibiting platelet function and interfere with platelet function by virtue of their antioxidant effect.

Design: We tested the effect of 2 flavonoids, quercetin and catechin, on collagen-induced platelet aggregation and hydrogen peroxide and on platelet adhesion to collagen.

Results: Catechin (50–100 µmol/L) and quercetin (10–20 µmol/L) inhibited collagen-induced platelet aggregation and platelet adhesion to collagen. The combination of 25 µmol catechin/L and 5 µmol quercetin/L, neither of which had any effect on platelet function when used alone, significantly inhibited collagen-induced platelet aggregation and platelet adhesion to collagen. Such a combination strongly inhibited collagen-induced hydrogen peroxide production, calcium mobilization, and 1,3,4-inositol triphosphate formation.

Conclusions: These data indicate that flavonoids inhibit platelet function by blunting hydrogen peroxide production and, in turn, phospholipase C activation and suggest that the synergism among flavonoids could contribute to an understanding of the relation between the moderate consumption of red wine and the decreased risk of cardiovascular disease.

Key Words: Platelet aggregation • flavonoids • hydrogen peroxide • platelet adhesion • phospholipase C • quercetin • catechin • red wine • cardiovascular disease


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Moderate consumption of red wine is associated with a decrease in the incidence of cardiovascular events (1, 2). Components of red wine, such as flavonoids, have been implicated in such cardiovascular benefits because of their ability to inhibit platelet function. In fact, in vivo experimental studies in animals showed that both red wine and grape juice decreased platelet activation in stenosed canine coronary arteries (3). A similar effect was observed with the flavonoids quercetin and catechin, indicating that these components of red wine were involved in eliminating the flow reduction due to platelet activation (4). Several in vitro studies showed that flavonoids such as resveretrol, quercetin, and catechin inhibit platelet aggregation; nevertheless, a potential limitation of these studies was that the concentration used to achieve this inhibition was too high. Accordingly, some authors questioned the antiplatelet activity exerted in vivo by these red wine components (5). Note that investigations of the effects of flavonoids on platelet function to date focused on each component singly; whether flavonoids act synergistically to inhibit platelet activation has never been studied. Because more than one flavonoid circulates in human blood after red wine consumption, such synergism might be relevant because lower concentrations of flavonoids than those investigated previously could modulate platelet activity.

Another issue inherent to the antiplatelet effect of flavonoids is their mechanism of action. Even if the results of most studies show that flavonoids interact with arachidonic acid metabolism, thus inhibiting platelet thromboxane A2 production, the underlying mechanism has never been investigated (6, 7). Flavonoids are phenolic compounds, the antioxidant effects of which are related to radical scavenging rather than to metal chelation (8). It has been suggested that the inhibition of both platelet function and arachidonic acid metabolism depends on antioxidant activity, but no studies have investigated whether flavonoids interact with oxidant species formed on platelet activation. The aim of this study, therefore, was to investigate whether flavonoids 1) act synergistically to inhibit platelet function and 2) interfere with platelet function by virtue of an antioxidant effect.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Materials
32Pi and [3H]oleic acid were from Amersham (Arlington Heights, IL). Fura 2-AM and 2',7'-dichlorofluorescein diacetate (DCFH-DA) were from Molecular Probes (Eugene, OR) and Sepharose 2B was from Pharmacia (Uppsala, Sweden). Tetrapeptide Arg-Gly-Asp-Ser (RGDS) was from Bachem Feinchemikalien AG (Bubendorf, Switzerland). Type I collagen was from Mascia Brunelli (Milan, Italy). HPLC columns (Partisil 10 SAX) were from Whatman (Clifton, NJ). Bovine serum albumin, HEPES, acetylsalicylic acid, catechin, quercetin, fibrinogen, inorganic pyrophosphatase, digitonin, formaldehyde, indomethacin, creatine phosphate, and creatine phosphokinase were from Sigma Chemical Co (St Louis).

Platelet preparations
Human blood from drug-free, healthy volunteers was anticoagulated with citric acid:citrate:dextrose (9). Platelet-rich plasma was centrifuged at 800 x g for 20 min at room temperature and the pellet was suspended in a volume half that of the initial volume of autologous, platelet-poor plasma. The platelet suspensions were incubated for 1 h at 37°C with 3 µmol Fura 2-AM/L, 40 µmol DCFH-DA/L, 7.4 GBq (2 Ci) 32Pi/L, or 3.7 MBq (1 mCi) [3H]oleic acid/L. Platelets were washed by gel filtration on Sepharose 2B by using Ca2+-free Tyrode's buffer (134 mmol NaCl/L, 2.9 mmol KCl/L, 0.34 mmol Na2HPO4/L, and 2 mmol MgCl2/L) containing 0.2% bovine serum albumin, 5 mmol glucose/L, and 10 mmol HEPES/L, pH 7.35. Gel-filtered platelets (GFPs) were adjusted to a final concentration of 2 x 1011 cells/L. Because the addition of methanol to GFP suspensions in concentrations <0.5% did not induce any change in the response of GFPs to collagen, this ratio was used to obtain final concentrations of quercetin ranging from 5 to 20 µmol/L. Catechin and quercetin were added to GFP suspensions under continuous stirring for 30 min at 37°C and then removed by centrifugation at 800 x g for 20 min at room temperature.

Flow cytometric analysis and platelet aggregation
DCFH-DA was added to GFPs (final concentration: 40 µmol/L); after 15 min incubation with or without catechin and quercetin, GFPs were activated with collagen. The reaction was stopped with 2 mmol EGTA/L after 1 min. Samples were analyzed on a Coulter XL-MCL (Hialeah, FL) flow cytometer equipped with an argon laser (480-nm emission) set up to measure logarithmic forward light scatter, which is a measure of particle size; logarithmic 90° light scatter, which is a measure of cell granularity; and green (DCF) 510–550-nm fluorescence. The fluorescent signal generated by the probe was expressed as the stimulation index, which is the mean channel fluorescence intensity of stimulated platelets/mean channel fluorescence intensity of unstimulated platelets. In vitro platelet aggregation was evaluated according to Born (10). Collagen was used at concentrations of 2–4 mg/L.

Platelet cytosolic Ca2+ concentrations
Platelet cytosolic Ca2+ concentrations were measured by using the fluorescent indicator dye Fura-2, according to Grynkiewicz et al (11); the changes in fluorescence were then monitored with an SFM 25 fluorimeter (Kontron, Zurich, Switzerland) set at 340-nm excitation and 510-nm emission wavelengths.

Phospholipase C activation and platelet adhesion to collagen
1,3,4-Inositol triphosphate (IP3) production, an indicator of phospholipase C activation, was analyzed 30 s after platelet stimulation according to Pulcinelli et al (12). Collagen was used at a concentration of 10 mg/L, which was the lowest concentration able to induce a reproducible response. [3H]Oleic acid–labeled platelet suspensions were used to evaluate platelet adhesion to collagen (50 mg/L) according to Smith and Dangelmaier (13).

Statistical analysis
Data are reported as means ± SEMs. The responses under different experimental conditions were compared by using Student's t test and the Bonferroni test to assess specific differences between groups. Significance was set at P < 0.05. STATVIEW (Abacus Concepts Inc, Berkeley, CA) was used for the analysis.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Flow cytometric analysis
Flow cytometry uses the properties of DCFH-DA (14–16), which rapidly diffuses across cell membranes and is then trapped within the cell via a deacetylation reaction. In the presence of hydrogen peroxide, this compound is oxidized to dichlorofluorescein (DCF), which is highly fluorescent (17). The effect of scalar concentrations of quercetin and catechin on hydrogen peroxide production induced by 10 and 20 mg collagen/L are shown in Figure 1Go. Compared with untreated platelets, collagen-stimulated platelets enhanced the production of hydrogen peroxide, which was dependent on the concentration of collagen used. Catechin and quercetin inhibited collagen-induced hydrogen peroxide production by platelets. The combination of 5 µmol quercetin/L and 25 µmol catechin/L significantly reduced hydrogen peroxide formation induced by 10 and 20 mg collagen/L; neither compound alone had any inhibitory effect (data not shown).



View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 1. Mean (±SEM) hydrogen peroxide production in 2',7'-dichlorofluorescein diacetate–loaded platelets at baseline, after stimulation by collagen alone, and after stimulation by 10 mg collagen/L (A) or 20 mg collagen/L (B) with catechin (Cat; 50 and 100 µmol/L), quercetin (Q; 10 and 20 µmol/L), or Cat (25 µmol/L) + Q (5 µmol/L). Results were determined by cytofluorimetry. n = 5 experiments. SI, stimulation index. *,#Significantly different from collagen alone: *P < 0.05, #P < 0.01.

 
Platelet aggregation
The effect of catechin and quercetin on platelet aggregation was measured by using 2 different concentrations of collagen. Both catechin and quercetin inhibited collagen-induced platelet aggregation. The degree of inhibition was dependent on the concentration of collagen used. Thus, 100 µmol catechin/L inhibited {approx}75% platelet aggregation induced by 2 mg collagen/L and inhibited {approx}39% platelet aggregation induced by 4 mg collagen/L. In platelets treated with 20 µmol quercetin/L, the degree of inhibition of collagen-induced platelet aggregation (2 and 4 mg/L) was 50% and 43%, respectively. The combination of 25 µmol catechin/L and 5 µmol quercetin/L, which did not affect platelet aggregation when used alone, significantly inhibited (55%) platelet aggregation induced by both concentrations of collagen (Figure 2Go).



View larger version (14K):
[in this window]
[in a new window]
  		FIGURE 2. Mean (±SEM) platelet aggregation at baseline, after stimulation by collagen alone, and after stimulation by 2 mg collagen/L (A) or 4 mg collagen/L (B) with catechin (Cat; 50 and 100 µmol/L), quercetin (Q; 10 and 20 µmol/L), or Cat (25 µmol/L) + Q (5 µmol/L). n = 5 experiments. *,#Significantly different from collagen alone: *P < 0.05, #P < 0.01.

 
Changes in intracellular calcium concentration
Calcium mobilization, expressed as a percentage change in intracellular calcium concentration, was inhibited by catechin and quercetin. In platelets stimulated with 4 mg collagen/L, 100 µmol catechin/L and 20 µmol quercetin/L significantly decreased calcium mobilization by 71% and 65%, respectively. The incubation of platelets with 25 µmol catechin/L plus 5 µmol quercetin/L significantly inhibited calcium mobilization by 71%. A similar result was observed when calcium mobilization was induced by 8 mg collagen/L (Figure 3Go).



View larger version (13K):
[in this window]
[in a new window]
  		FIGURE 3. Mean (±SEM) percentage changes ({Delta}) in intraplatelet calcium concentrations at baseline, after stimulation by collagen alone, and after stimulation by 4 mg collagen/L (A) or 8 mg collagen/L (B) with catechin (Cat; 50 and 100 µmol/L), quercetin (Q; 10 and 20 µmol/L), or Cat (25 µmol/L) + Q (5 µmol/L). n = 5 experiments. *,#Significantly different from collagen alone: *P < 0.05, #P < 0.01.

 
Phospholipase C activation
[32P]IP3 production in collagen-stimulated platelets was inhibited by catechin and quercetin: 10 mg collagen/L, 100 µmol catechin/L, and 20 µmol quercetin/L significantly decreased IP3 production by 50% and 93%, respectively. The incubation of platelets with 25 µmol catechin/L plus 5 µmol quercetin/L significantly inhibited IP3 production by 72%; similar effects were observed when platelets were stimulated with 20 mg collagen/L (Figure 4Go), but the degree of inhibition was less, although still significant.



View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 4. Mean (±SEM) percentage changes ({Delta}) in 1,3,4-inositol trisphosphate (IP3) formation in platelets at baseline, after stimulation by collagen alone, and after stimulation by 10 mg collagen/L (A) or 20 mg collagen/L (B) with catechin (Cat; 50 and 100 µmol/L), quercetin (Q; 10 and 20 µmol/L), or Cat (25 µmol/L) + Q (5 µmol/L). n = 5 experiments. *,#Significantly different from collagen alone: *P < 0.05, #P < 0.01.

 
Platelet adhesion to collagen
Activation of platelets by collagen is a multistep event. In fact, after an initial attachment to platelets through second messenger pathways, collagen stimulates release of thromboxane and ADP, which are important platelet agonists that induce aggregation (18). To study platelet adhesion to collagen (50 mg/L) without the interference of aggregation and activation induced by all the known agonists released from platelet granules on collagen stimulation, platelets were preincubated with the cyclooxygenase inhibitor aspirin, with the ADP-removing system creatine phosphate and creatine phosphokinase, and with the fibrinogen-fibronectin antagonist RGDS (13).

The adhesion of platelets to 50 µmol collagen/L in the presence of catechin (50 and 100 µmol/L), quercetin (10 and 20 µmol/L), and catechin (25 µmol/L) plus quercetin (5 µmol/L) is reported in Figure 5Go. Catechin or quercetin alone inhibited platelet adhesion to collagen, which was almost completely suppressed by 100 µmol catechin/L and 20 µmol quercetin/L. Incubation of platelets with 25 µmol catechin/L plus 5 µmol quercetin/L inhibited platelet adhesion significantly by 85%.



View larger version (13K):
[in this window]
[in a new window]
  		FIGURE 5. Mean (±SEM) percentage changes ({Delta}) in platelet adhesion to collagen at baseline, after stimulation by collagen alone, and after stimulation by 10 mg collagen/L (A) or 20 mg collagen/L (B) with catechin (Cat; 50 and 100 µmol/L), quercetin (Q; 10 and 20 µmol/L), or Cat (25 µmol/L) + Q (5 µmol/L). n = 5 experiments. #Significantly different from collagen alone, P < 0.01.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Previous studies showed that quercetin (40–100 µmol/L) and catechin (100–420 µmol/L) inhibited platelet aggregation in vitro (5–7). We confirmed this effect using 50 and 100 µmol catechin/L. Lower concentrations of quercetin were sufficient to inhibit platelet function; the inhibitory effect achieved with 20 µmol quercetin/L was the same as that observed with 100 µmol catechin/L. The disagreement with the data reported in the literature might be dependent on our experimental procedure. Before the addition of the agonist, platelets were incubated with flavonoids for 30 min, an incubation time that was much longer than that used previously ({approx}10 min) in studies of the effects of flavonoids on platelet function.

It has been suggested that the effect of flavonoids on platelet aggregation is dependent on the inhibition of the cyclooxygenase pathway, resulting from the inhibitory effect of flavonoids on the platelet formation of thromboxane A2, a potent aggregating and vasoconstricting agent (5–7). It was suggested that the underlying mechanism resides in the antioxidant activity of flavonoids, but this hypothesis has never been investigated. We showed recently that collagen-induced platelet aggregation is associated with a burst of hydrogen peroxide that, in turn, contributes to the activation of platelet function through calcium mobilization and inositol pathway activation (19). Therefore, this experimental model is considered ideal to assess whether flavonoids behave as antioxidant agents when incubated with platelets. We showed that both quercetin and catechin significantly inhibited the release of platelet hydrogen peroxide elicited by collagen, with almost complete suppression when the 2 flavonoids were used in combination. An apparent discrepancy in our findings is that the inhibition of collagen-induced hydrogen peroxide release by quercetin or catechin, both alone and in combination, was more marked than was the inhibition of platelet aggregation. This is likely dependent on the fact that hydrogen peroxide represents only one pathway through which collagen induces platelet aggregation. On the basis of the above-reported antioxidant properties, it is presumed that platelet aggregation could not be completely suppressed by flavonoids.

According to a previous study showing that hydrogen peroxide contributes to activating the phosphoinositol pathway, quercetin and catechin alone or in combination significantly inhibited calcium mobilization and IP3 formation because of their ability to quench hydrogen peroxide. Therefore, these findings indicate that quercetin and catechin inhibit platelet function by virtue of antioxidant activity. This hypothesis is corroborated by a previous study (20) in which we tested the effect of another antioxidant, vitamin E, in the same experimental model. Vitamin E significantly inhibited platelet activation at a concentration of 50 µmol/L, which is similar to the concentrations of quercetin and catechin used in the present study. However, a more precise comparison between vitamin E and flavonoids could not be done because lower concentrations of vitamin E were not investigated.

The close relation between red wine consumption and the inhibition of platelet function has been observed in several experimental studies. In fact, intragastric administration of 4.0 mL red wine/kg body wt completely suppressed platelet activation in a canine model of coronary stenosis (3). Even though flavonoid concentrations in peripheral blood were not measured after red wine administration, further study on the same experimental model showed that flavonoids inhibited platelet activation, thus suggesting their possible involvement in the inhibition of platelet function (4). We cannot be certain that the concentrations used in our experiments correspond to those observed in human circulation after red wine consumption because there are no data concerning this point. However, with other sources of flavonoids, such as onions and tea, the plasma flavonoid concentrations ranged from 0.6 to 13 µmol/L (19–22), which are similar to those achieved by the combination of quercetin and catechin in the present study. In our experiments, the incubation of platelets with 5 µmol quercetin/L plus 20 µmol catechin/L, which singly had no effect on platelet function, was associated with a significant inhibition of platelet activation. Note that even though the stimulation was carried out with high concentrations of collagen (8–20 mg/L), which were technically necessary to detect calcium mobilization and IP3 production (19), the combination of quercetin and catechin inhibited platelet function.

The combination of catechin and quercetin elicited even more profound effects on platelet adhesion, which was almost completely suppressed when platelets were treated with the 2 flavonoids. To the best of our knowledge, this is the first evidence that flavonoids inhibit platelet adhesion. Because of the biological importance of platelet adhesion to collagen in the initiation and progression of the atherosclerotic process (23), this finding may be important to further understand the relation between red wine, flavonoids, and cardiovascular disease.

In conclusion, our study showed for the first time that flavonoids such as quercetin and catechin act synergistically to inhibit platelet adhesion to collagen and collagen-induced platelet aggregation. These data further contribute to the understanding of the relation between moderate consumption of red wine and a decreased risk of cardiovascular disease.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. More RD, Pearson TA. Moderate alcohol consumption and coronary artery disease. Medicine 1986;65:245–67.
  2. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329: 1829–34.[Abstract/Free Full Text]
  3. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995;91:1182–8.[Abstract/Free Full Text]
  4. Slane PR, Qureshi AA, Folts JD. Platelet inhibition in stenosed canine arteries by quercetin and rutin, polyphenolic flavonoids found in red wine. Clin Res 1994;42:169A (abstr).
  5. Janssen PLTMK, Mensink RP, Cox FJJ, et al. Effect of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and dietary supplement study. Am J Clin Nutr 1998;67:255–62.[Abstract]
  6. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveretrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995;235:207–19.[Medline]
  7. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996;246:163–82.[Medline]
  8. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidant: determination of radical-scavenging efficiencies. Methods Enzymol 1990;186:343–67.[Medline]
  9. Aster RH, Jandel JH. Platelet sequestration in man. I. Methods. J Clin Invest 1964;43:843–55.
  10. Born GVR. The aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194:927–9.[Medline]
  11. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440–50.[Abstract/Free Full Text]
  12. Pulcinelli FM, Gazzaniga PP, Salganicoff L. Use of Zn-pyrophosphatase in the high-performance liquid chromatography analysis of cell extracts containing 32P-labelled inositol phosphates. J Chromatogr 1992;575:51–5.[Medline]
  13. Smith JB, Dangelmaier C. Determination of platelet adhesion to collagen and the associated formation of phosphatidic acid and calcium mobilization. Anal Biochem 1990;187:173–8.[Medline]
  14. Burrow S, Valet G. Flow-cytometric characterization of stimulation, free radical formation, peroxidase activity and phagocytosis of human granulocytes with 2,7-dichlorofluorescein (DCF). Eur J Cell Biol 1987;43:128–33.[Medline]
  15. Del Principe D, Menichelli A, De Matteis W, Di Giulio S, Giordani M. Hydrogen peroxide is an intermediate in platelet activation cascade triggered by collagen, but not by thrombin. Thromb Res 1991; 62:365–75.[Medline]
  16. Maresca M, Colao C, Leoncini G. Generation of hydrogen peroxide in resting and activated platelets. Cell Biochem Funct 1992;10:79–85.[Medline]
  17. Leoncini G, Maresca M, Colao C. Oxidative metabolism of human platelets. Biochem Int 1991;25:647–55.[Medline]
  18. Kinlough-Rathbone RL, Packham MA, Reimers HJ, Cazenave JP, Mustard JF. Mechanism of platelet shape change, aggregation and release induced by collagen, thrombin or A23187. J Lab Clin Med 1977;90:707–12.[Medline]
  19. Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 1998;91:484–90.[Abstract/Free Full Text]
  20. Pignatelli P, Pulcinelli FM, Lenti L, Ghiselli A, Gazzaniga PP, Violi F. Vitamin E inhibits collagen-induced platelet activation by blunting hydrogen peroxide. Arterioscler Thromb Vasc Biol 1999;19:2542–7.[Abstract/Free Full Text]
  21. Maini G, Serafini M, Azzini E, Ferro-Luzzi A. Application of a new high-performance liquid chromatographic method for measuring selected polyphenols in human plasma. J Chromatogr 1996;692: 311–7.
  22. Hollman PCH, Van der Gaag MS, Mengelers MJB, de Vries JHM, Katan MB. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med 1996;21:703–7.[Medline]
  23. van Zanten GH, de Graaf S, Slootweg PJ, Heijnen HF, Connolly TM. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest 1994;93:615–32.
Received for publication November 2, 1999. Accepted for publication April 5, 2000.




This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
I. Erlund, R. Koli, G. Alfthan, J. Marniemi, P. Puukka, P. Mustonen, P. Mattila, and A. Jula
Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol
Am. J. Clinical Nutrition, February 1, 2008; 87(2): 323 - 331.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. Lin, K. M. Rexrode, F. Hu, C. M. Albert, C. U. Chae, E. B. Rimm, M. J. Stampfer, and J. E. Manson
Dietary Intakes of Flavonols and Flavones and Coronary Heart Disease in US Women
Am. J. Epidemiol., June 1, 2007; 165(11): 1305 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
P. Pignatelli, S. Di Santo, B. Buchetti, V. Sanguigni, A. Brunelli, and F. Violi
Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment
FASEB J, June 1, 2006; 20(8): 1082 - 1089.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
R. Hirano-Ohmori, R. Takahashi, Y. Momiyama, H. Taniguchi, A. Yonemura, S. Tamai, K. Umegaki, H. Nakamura, K. Kondo, and F. Ohsuzu
Green Tea Consumption and Serum Malondialdehyde-Modified LDL Concentrations in Healthy Subjects
J. Am. Coll. Nutr., October 1, 2005; 24(5): 342 - 346.
[Abstract] [Full Text] [PDF]

Home page
 Food Science and Technology InternationalHome page
R. M. Lamuela-Raventos, A. I. Romero-Perez, C. Andres-Lacueva, and A. Tornero
Review: Health Effects of Cocoa Flavonoids
Food Science and Technology International, June 1, 2005; 11(3): 159 - 176.
[Abstract] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. L Keen, R. R Holt, P. I Oteiza, C. G Fraga, and H. H Schmitz
Cocoa antioxidants and cardiovascular health
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 298S - 303S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
H. Sies, T. Schewe, C. Heiss, and M. Kelm
Cocoa polyphenols and inflammatory mediators
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 304S - 312S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
G. I. Togna, A. R. Togna, M. Franconi, C. Marra, and M. Guiso
Olive Oil Isochromans Inhibit Human Platelet Reactivity
J. Nutr., August 1, 2003; 133(8): 2532 - 2536.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
K. J Murphy, A. K Chronopoulos, I. Singh, M. A Francis, H. Moriarty, M. J Pike, A. H Turner, N. J Mann, and A. J Sinclair
Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function
Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1466 - 1473.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. Shanmuganayagam, M. R. Beahm, H. E. Osman, C. G. Krueger, J. D. Reed, and J. D. Folts
Grape Seed and Grape Skin Extracts Elicit a Greater Antiplatelet Effect When Used in Combination than When Used Individually in Dogs and Humans
J. Nutr., December 1, 2002; 132(12): 3592 - 3598.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. M Geleijnse, L. J Launer, D. A. van der Kuip, A. Hofman, and J. C. Witteman
Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study
Am. J. Clinical Nutrition, May 1, 2002; 75(5): 880 - 886.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
F. Violi, P. Pignatelli, F.M. Pulcinelli, J. E. Freedman, C. Parker III, L. Li, J. A. Perlman, B. Frei, V. Ivanov, L. R. Deak, et al.
Synergism Among Flavonoids in Inhibiting Platelet Aggregation and H2O2 Production Response
Circulation, February 26, 2002; 105 (8): e53 - e53.
[Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Yoshizumi, K. Tsuchiya, K. Kirima, M. Kyaw, Y. Suzaki, and T. Tamaki
Quercetin Inhibits Shc- and Phosphatidylinositol 3-Kinase-Mediated c-Jun N-Terminal Kinase Activation by Angiotensin II in Cultured Rat Aortic Smooth Muscle Cells
Mol. Pharmacol., October 1, 2001; 60(4): 656 - 665.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. J. Duffy, J. A. Vita, M. Holbrook, P. L. Swerdloff, and J. F. Keaney Jr
Effect of Acute and Chronic Tea Consumption on Platelet Aggregation in Patients With Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1084 - 1089.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. Misikangas, R. Freese, A. M. Turpeinen, and M. Mutanen
High Linoleic Acid, Low Vegetable, and High Oleic Acid, High Vegetable Diets Affect Platelet Activation Similarly in Healthy Women and Men
J. Nutr., June 1, 2001; 131(6): 1700 - 1705.
[Abstract] [Full Text]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pignatelli, P.
Right arrow Articles by Violi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pignatelli, P.
Right arrow Articles by Violi, F.
Agricola
Right arrow Articles by Pignatelli, P.
Right arrow Articles by Violi, F.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS